Extera Partners Your Corporate Development Team For Successful Industry Partnering

Corporate Development Services

Extera focuses on providing superior corporate development services to life science companies. We specialize in planning and executing strategic transactions with industry partners and financial investors across the globe. Extera takes a pragmatic and aggressive approach to corporate development and is committed to closing high value transactions for our clients. Since its inception in 2007, Extera has supported a range of clients from early start-ups to global life science companies.

The firm works diligently and persistently until our clients’ strategic objectives are met. Extera’s negotiation skills, access to decision makers, global presence and commitment are responsible for its reputation as a premier life science corporate development advisory firm. Our areas of focus include biotechnology, specialty pharmaceuticals, generics, medical technology, diagnostics and clinical imaging. Extera operates out of offices in the US, Europe, Japan and Israel.

Our
Team

Extera’s team has been working together for over a decade. Our team’s collective experience exceeds one hundred and fifty years of corporate development and management experience in the biotechnology and medical device sectors.

Track Record

Extera has facilitated a broad range of strategic transactions including mergers, structured acquisitions, research and development collaborations, technology and product licensing, global distribution transactions and financial investments by venture capital and private equity firms.

Private Placement

Undisclosed

Acquisition

$83,000,000

Collaboration

$500,000,000

Collaboration

$350,000,000

Private Placement

Undisclosed

Private Placement

Undisclosed

Acquisition

Undisclosed

Acquisition

$93,000,000

Collaboration

Undisclosed

Licensing

$75,000,000

Private Placement

$28,000,000

Licensing

$8,000,000

Collaboration

Undisclosed

Collaboration

Undisclosed

Collaboration

Undisclosed

Acquisition

$300,000,000

Acquisition

$250,000,000

Funding & Distribution

$5,000,000

Collaboration

Undisclosed

Private Placement

$8,000,000

Distribution

Undisclosed

Distribution

Undisclosed

Private Placement

$21,000,000

Private Placement

Undisclosed

Licensing

$95,000,000

Reverse Take Over

$65,000,000

 
 

Case studies

Extera’s extensive analysis and planning, aggressive execution, dedication and commitment even under challenging situations are responsible for the high rate of success in closing transactions.

Venture Creation

Extera leverages broad market reach and operational expertise to create and accelerate new biotechnology and medical device ventures that seek to improve clinical outcomes, enhance quality of life and reduce healthcare costs.

Contact
Us

 

Extera Partners Headquarters:

 

222 Third Street
Suite #2240
Cambridge, MA 02142, USA
Tel: 617-225-7700

 

Please call us or contact Extera via e-mail with any inquiry

 

exteramap
 
ep_logo4_white

 

© Extera Partners, 2017